Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 962.40 Million | USD 2157.30 Million | 14.40% | 2023 |
FrequentlyAsked Questions
The main reasons anticipated to propel the glycobiology/glycomics market during the forecast period are Developing pharmaceutical and biopharmaceutical firm The primary reasons driving the Glycomics/Glycobiology Market are technological investments and economic development.
According to the report, the global glycobiology/glycomics market size was worth USD 962.40 million in 2021 and is estimated to grow to USD 2157.30 million by 2028, with a compound annual growth rate (CAGR) of approximately 14.40 percent over the forecast period.
The global market is predicted to be dominated by North America, followed by Europe. The greatest proportion of North America is mostly due to increased glycomics research spending, rising R&D investments in pharmaceutical businesses for medication discovery, and the presence of all significant competitors.
Some of the main competitors dominating the global glycobiology/glycomics market include - Agilent Technologies, Waters Corporation, Lectenz Bio, Takara Bio, Thermo Fisher Scientific, Merck KGaA, New England Biolabs, ProZyme, Shimadzu Corporation, and S Bio.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed